Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126913051 | 12691305 | 1 | I | 20160412 | 20160819 | 20160826 | 20160826 | EXP | PHHY2016IT115032 | SANDOZ | 53.47 | YR | F | Y | 0.00000 | 20160826 | OT | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126913051 | 12691305 | 1 | PS | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | Oral | 28 DF, ONCE/SINGLE | 77040 | 28 | DF | TABLET | 1X | ||||||
| 126913051 | 12691305 | 2 | SS | FELISON | FLURAZEPAM MONOHYDROCHLORIDE | 1 | Oral | 15 DF, ONCE/SINGLE | 0 | 15 | DF | HARD-GELATIN CAPSULE | 1X |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126913051 | 12691305 | 1 | Product used for unknown indication |
| 126913051 | 12691305 | 2 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126913051 | 12691305 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126913051 | 12691305 | Drug abuse | |
| 126913051 | 12691305 | Suicide attempt |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126913051 | 12691305 | 1 | 20160412 | 20160412 | 0 | |
| 126913051 | 12691305 | 2 | 20160412 | 20160412 | 0 |